NEW YORK, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Baird Medical Investment Holdings Limited (NASDAQ: BDMD) (“Baird Medical” or the “Company”), a healthcare innovator dedicated to microwave ablation (MWA) technology, today announced that the Company received a notification letter (the “Notification Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”), dated November 2, 2026, notifying the Company that it is not in compliance with the minimum bid price requiremen
Quarter included presentation at H.C. Wainwright Global Investment Conference, strategic partnership with Alpmed, new regulatory registrations, and continued physician trainingNEW YORK, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Baird Medical Investment Holdings Ltd. (“Baird Medical” or the “Company”) (NASDAQ: BDMD), a medical device company focused on the development and commercialization of minimally invasive treatment technologies, today highlighted key business and operational developments from the t
NEW YORK, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Baird Medical Investment Holdings Limited (“Baird Medical” or the “Company”) (Nasdaq: BDMD), a global medical technology company focused on the development and commercialization of minimally invasive treatment solutions, today announced that management will present at the H.C. Wainwright 28th Annual Global Investment Conference in New York City. H.C. Wainwright 28th Annual Global Investment ConferenceDate: Wednesday, September 16, 2026Time: 11:30 a.m.
COPENHAGEN, Denmark, Sept. 14, 2026 (GLOBE NEWSWIRE) -- Baird Medical Investment Holdings Ltd. (“Baird Medical” or the “Company”) (Nasdaq: BDMD)...
By Tom Kerr, CFA NASDAQ: BDMD READ THE FULL BDMD RESEARCH REPORT Interim Financial Results On September 3, 2026, Baird Medical (NASDAQ: BDMD) released financial results for the 6-month period ending June 30, 2026, which showed strong revenue growth from non-China regions. Revenue grew 24.6% to approximately $9.9 million in the 1st half of 2026, compared with $8.0 million in the prior-year period.
NASDAQ: BDMD Tom Kerr, CFA: Hello everyone, my name is Tom Kerr. I'm a senior equity analyst at Zacks Small Cap Research , and welcome to another episode of our Fireside Chat program. Today we have the CEO of the U.S. Region for Baird Medical , Mark Saxton. Baird Medical (NASDAQ: BDMD) is a leading provider of microwave ablation technology, providing solutions for treating thyroid nodules, breast
Revenue increase driven by significant growth in the United States and other strategic marketsNEW YORK, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) (“Baird Medical” or the “Company”), today announced preliminary unaudited financial results for the six months ended June 30, 2026. Revenue for the first half of 2026 was approximately $9.9 million, an increase of 24.6% over $8.0 million reported for the six months ended June 30, 2025. The increase in reve
This is the newest page. Registered accounts read further back.